Product Details for: TUDRIQEV

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Suspension
Intratumor
10^6-10^7 PFU/mL
Single-Dose Vial
351(a)
TUDRIQEV
Rx
Proper Name
vusolimogene oderparepvec-wtpg
BLA Number
125827
Applicant
Replimune, Inc.
Original Approval Date
August 6, 2026
Date of First Licensure
RETURN TO SEARCH RESULTS